CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-08-18 | ACCBT Corp. 10% owner | Exercise or conversion · Warrant to Purchase Common Stock | +3,529,166 | 3,529,166 | ||
| 2009-08-18 | ACCBT Corp. 10% owner | Returned to the company · Warrant to Purchase Common Stock | −1,008,334 | 0 | ||
| 2009-08-18 | ACCBT Corp. 10% owner | Exercise or conversion · Warrant to Purchase Common Stock | +1,008,334 | 1,008,334 | ||
| 2009-08-18 | ACCBT Corp. 10% owner | Exercise or conversion · Right to Acquire Common Stock | +14,166,667 | 22,416,667 | ||
| 2009-06-29 | Efrati Abraham Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,000,000 | 1,000,000 | ||
| 2009-06-29 | STOLICK DAVID Chief Financial Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2009-03-16 | TAUB MALCOLM S Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2008-09-08 | ACCBT Corp. 10% owner | Exercise or conversion | +4,125,000 | $0.18 | $750K | 18,506,925 |
| 2008-09-08 | ACCBT Corp. 10% owner | Exercise or conversion · Warrant to Purchase Common Stock | +3,529,166 | 3,529,166 | ||
| 2008-09-08 | ACCBT Corp. 10% owner | Exercise or conversion · Warrant to Purchase Common Stock | +1,008,334 | 1,008,334 | ||
| 2008-09-08 | ACCBT Corp. 10% owner | Exercise or conversion · Right to Acquire Common Stock | −4,125,000 | 8,250,000 | ||
| 2008-09-08 | ACCBT Corp. 10% owner | Exercise or conversion · Right to Acquire Warrant to Purchase Common Stock | −4,537,500 | 9,075,000 | ||
| 2008-08-27 | Javitt Jonathan C Director | Other acquisition | +0 | 0 | ||
| 2008-08-27 | Javitt Jonathan C Director | Option exercise | +1,000,000 | $0.01 | $10K | 960,000 |
| 2008-08-27 | Javitt Jonathan C Director | Sale | −40,000 | $0.25 | $10K | 960,000 |
| 2008-08-27 | Javitt Jonathan C Director | Option exercise · Warrant to Purchase Common Stock | −1,000,000 | $0.01 | $10K | 0 |
| 2008-04-03 | ACCBT Corp. 10% owner | Exercise or conversion | +2,000,000 | $0.18 | $364K | 14,381,925 |
| 2008-04-03 | ACCBT Corp. 10% owner | Exercise or conversion · Warrant to Purchase Common Stock | +4,537,500 | 4,537,500 | ||
| 2008-04-03 | ACCBT Corp. 10% owner | Exercise or conversion · Right to Acquire Common Stock | −4,125,000 | 12,375,000 | ||
| 2008-04-03 | ACCBT Corp. 10% owner | Exercise or conversion · Right to Acquire Warrant to Purchase Common Stock | −4,537,500 | 13,612,500 |
Page 18 of 22 · 426 trades